Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GreenGene F in Severe Hemophilia A
NCT01619046Phase 3Unknown
- Sponsor
- GC Biopharma
- Start
- Mar 2013
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of GreenGene F in hemophilia A, sponsored by GC Biopharma. Status: unknown.
02
Drugs
GreenGene F
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01619046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01619046.